Nathan Yozwiak, PhD, is the Head of Research at the Gene and Cell Therapy Institute (GCTI) of Mass General Brigham, a translational medicine institute affiliated with Mass General Hospital and Brigham and Women’s Hospital. Dr. Yozwiak is a scientific leader with 20+ years’ experience in virology research, broadly focused on using genomics to investigate viruses for gene therapy and to understand human disease. Prior to MGB, he was the founding Director of Viral Genomics at Ring Therapeutics, a Flagship Pioneering-backed biotech, where his work uncovering commensal viruses as a novel gene delivery platform enabled fund raising >$200M in three years. Previously, he was Associate Director of Viral Genomics at the Broad Institute and the Department of Organismal and Evolutionary Biology at Harvard University, where he managed multi-site international research consortia studying virus diagnostics and evolution. At GCTI, he is overseeing and supporting a large group in investigators, whose mission is to bridge early-stage discovery research on gene therapies with patient populations.